The Cell and Gene Therapy Catapult (CGT Catapult) has published recommendations on how the UK can continue to maintain its global advantage in the adoption of Advanced Therapy Medicinal Products…

The UK has been highlighted as a leader in clinical trials for Advanced Therapy Medicinal Products (ATMPs), after a report published by the Cell and Gene Therapy Catapult (CGT Catapult)…

…will bring together two highly synergistic approaches – quantitative decision making and state-of-the-art generative chemistry, combined with real-time biological and biochemical profiling and data generation, to significantly accelerate the design-make-test-analyse…

…specialised software with steep learning curves. Official comments “ChemDraw software and the ChemOffice+ Cloud platform are all about simplifying, facilitating, and accelerating chemistry communication to transform drawings into shareable knowledge,”…

…have serious limitations The medicinal product is likely to offer major advantage over methods currently used in the UK The potential adverse effects of the medicinal product are likely to…

Domainex has purchased over £1 million worth of new Waters equipment to enhance its capabilities in analytical chemistry, bioanalytical sciences and in vitro absorbance, distribution, metabolism and excretion (ADME) assays….

…in this area, especially in our structure-based offerings. This has the added benefit of freeing up space at our closely located Chesterford Research Park site to further expand our chemistry…

…has a PhD in Biochemistry and Biomedical Sciences and a Postdoctoral Fellow from Princeton University. The second is the Smart Assays Lab in the Weizmann Science Park in Israel. This…

…epilepsy who have not been adequately controlled despite a history of treatment with at least two anti-epileptic medicinal products5. References Scottish Medicines Consortium. Cenobamate. Available at: https://www.scottishmedicines.org.uk/medicines-advice/cenobamate-ontozry-full-smc2408/ Accessed February 2022….

…goal in SLE to reduce the risk of organ damage.8,9 The approval follows the recommendation by the Committee for Medicinal Products for Human Use of the European Medicines Agency in…

…for high school students of colour to enter into STEM fields, especially chemistry and scientific innovation; provide scholarship funding to US high school students of colour to support their college…

…medicinal chemistry services to develop the initial hits. To further advance this research into the role of FLIP inhibitors in cancer, Queen’s secured a Wellcome Trust Seeding Drug Discovery award….

…The UQ Diamantina Institute, included collaborations with Umeå University, Sweden; UQ School of Chemistry and Molecular Biosciences; Australian Infectious Diseases Research Centre; Institute for Molecular Bioscience; Mater Research Institute; Telethon…

…allows targeted protein degraders to attack targets previously thought ‘undruggable’ ie. that have failed traditional medicinal chemistry approaches. It constitutes a platform technology applicable across diverse disease areas. “Among the…

…the second half of 2023. The technology Avacta’s chemistry is used to modify chemotherapy drugs to render them inactive in the circulation until they enter the tumour micro-environment where they…

…a medicine that may potentially benefit those affected by this rare, life-threatening condition.” References Community Register of orphan medicinal products. European Commission (EC). Available from: https://ec.europa.eu/health/documents/community-register/html/o2548.htm [Last accessed December 2021]….